Ушбу иш иқтибос қилган ишлар

42 та иш

Иш: The Use of Nivolumab in Colorectal Cancer with Lynch Syndrome. A Case Report

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang +32
Мақола20155 иқтибос
ABI
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong +17
Мақола20183 иқтибос
ABI
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith +43
Мақола20172 иқтибос
ABI
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
John M. Carethers
Шарҳ мақола20152 иқтибос
ABI
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Fay Kastrinos
Мақола20092 иқтибос
ABI
Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II)
Henry T. Lynch, Patrice Watson, Stephen J. Lanspa +5
Мақола19882 иқтибос
ABI
Screening for hereditary non-polyposis colorectal cancer: A study of 22 kindreds in The Netherlands
Hans F. A. Vasen, Frieda C. A. den Hartog Jager, Fred H. Menko +1
Мақола19892 иқтибос
ABI
Inheritance of colorectal cancer
Randall W. Burt
Мақола20072 иқтибос
ABI
Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC)
Hye-Jung Han, Masakazu Maruyama, Shozo Baba +2
Мақола19952 иқтибос
ABI
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations
Patrick Joost, Christina Therkildsen, Mev Dominguez–Valentin +2
Мақола20152 иқтибос
ABI
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Hans F. A. Vasen, Jukka‐Pekka Mecklin, P. Meera Khan +1
Мақола19912 иқтибос
ABI
Lynch syndrome in the 21st century: clinical perspectives
Ashish K. Tiwari, Hemant K. Roy, H. T. Lynch
Шарҳ мақола20152 иқтибос
ABI
Cancer Risks Associated With Germline Mutations in <emph type="ital">MLH1</emph>, <emph type="ital">MSH2</emph>, and <emph type="ital">MSH6</emph> Genes in Lynch Syndrome
Valérie Bonadona
Мақола20112 иқтибос
ABI
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pål Møller, Toni T. Seppälä, Inge Bernstein +33
Мақола20152 иқтибос
ABI
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs +15
Мақола20172 иқтибос
ABI
Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)
Heinz‐Josef Lenz, Eric Van Cutsem, María Luisa Limón +15
Мақола20182 иқтибос
ABI
Tumor Testing for Microsatellite Instability to Identify Lynch Syndrome: New Insights Into an Old Diagnostic Strategy
Matthew B. Yurgelun, Fay Kastrinos
Бошқа20182 иқтибос
ABI
Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine
Laura Valle, Eduardo Vilar, Sean V. Tavtigian +1
Шарҳ мақола20182 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI